TP53 and skin squamous cell carcinoma: In primary cSCCs, a mutation frequency of TP53 is 50–60% [37,46], while in metastatic cSCCs, nearly 95% of samples show genetic alterations in the TP53, highlighting the role of chronic UV exposure in the progression of cSCC [38,39].